• 1. An integrated microfluidic platform for sensitive and rapid detection of biological toxins?
  Robert J. Meagher,Anson V. Hatch,Ronald F. Renzi,Anup K. Singh Lab Chip, 2008,8, 2046-2053
• 2. An insight into the role of side chains in the microstructure and carrier mobility of high-performance conjugated polymers?
  Jianyao Huang,Dong Gao,Zhihui Chen,Weifeng Zhang Polym. Chem., 2021,12, 2471-2480
• 3. An artificial photosynthetic system for photoaccumulation of two electrons on a fused dipyridophenazine (dppz)–pyridoquinolinone ligand?
  Philipp Traber,Stephan Kupfer,Stefanie Gr?fe,Isabelle Baussanne,Martine Demeunynck,Jean-Marie Mouesca,Serge Gambarelli,Vincent Artero,Murielle Chavarot-Kerlidou Chem. Sci., 2018,9, 4152-4159
• 4. An integrated cathode and solid electrolyte via in situ polymerization with significantly reduced interface resistance?
  Jialiang Yuan,Ran Dong,Yuan Li,Yang Liu,Zhuo Zheng,Yuxia Liu,Yan Sun,Benhe Zhong,Zhenguo Wu,Xiaodong Guo Chem. Commun., 2021,57, 13004-13007
• 5. An integrated process of CO2 capture and in situ hydrogenation to formate using a tunable ethoxyl-functionalized amidine and Rh/bisphosphine system?
  Yu-Nong Li,Liang-Nian He,Xian-Dong Lang,Xiao-Fang Liu,Shuai Zhang RSC Adv., 2014,4, 49995-50002

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Triazines Triazinones

5-Aza-7-Deazaguanine: A Comprehensive Overview

The compound with CAS No. 67410-64-4, commonly referred to as 5-Aza-7-deazaguanine, is a fascinating molecule that has garnered significant attention in the fields of organic chemistry, biochemistry, and pharmacology. This compound is a derivative of guanine, one of the four nucleobases essential for DNA and RNA synthesis. The 5-Aza-7-deazaguanine structure introduces unique modifications that have opened up new avenues for research and potential applications in drug development.

5-Aza-7-deazaguanine is characterized by its distinctive chemical structure, which includes an aza (nitrogen-containing) group at position 5 and the removal of a diazine ring at position 7. This structural modification alters the molecule's electronic properties and reactivity compared to its parent compound, guanine. The compound's structure has been extensively studied using advanced spectroscopic techniques such as NMR and X-ray crystallography, providing insights into its conformational flexibility and interactions with other biomolecules.

Recent studies have highlighted the potential of 5-Aza-7-deazaguanine in the development of antiviral and anticancer agents. Its ability to inhibit key enzymes involved in viral replication and cancer cell proliferation has made it a promising candidate for therapeutic interventions. For instance, research published in *Nature Communications* demonstrated that 5-Aza-7-deazaguanine derivatives can effectively target RNA-dependent RNA polymerase in certain viral strains, showcasing their potential as antiviral agents.

In addition to its therapeutic applications, 5-Aza-7-deazaguanine has also been explored for its role in nucleic acid chemistry. The compound's unique structure allows it to form unusual base-pairing interactions, which could be harnessed for the design of novel nucleic acid analogs with enhanced stability or functionality. This property has led to its use in synthetic biology applications, where it serves as a building block for creating artificial genetic systems.

The synthesis of 5-Aza-7-deazaguanine involves a multi-step process that typically begins with the modification of guanine or its derivatives. Recent advancements in synthetic methodologies have enabled the production of this compound with higher yields and greater purity, facilitating its use in large-scale studies. Researchers have also explored green chemistry approaches to synthesize 5-Aza-7-deazaguanine, reducing the environmental impact of its production.

One of the most exciting developments involving 5-Aza-7-deazaguanine is its application in CRISPR-Cas9 gene editing systems. Studies have shown that this compound can enhance the efficiency of CRISPR-Cas9 by stabilizing guide RNA structures and improving their targeting accuracy. This breakthrough has significant implications for genome editing applications in both basic research and clinical settings.

Moreover, 5-Aza-7-deazaguanine has been investigated for its role in epigenetic regulation. Preclinical studies suggest that this compound can modulate histone acetylation levels, potentially offering new strategies for treating diseases associated with aberrant epigenetic modifications such as cancer and neurodegenerative disorders.

The pharmacokinetic properties of 5-Aza-7-deazaguanine have also been extensively studied to evaluate its suitability as a drug candidate. Research indicates that the compound exhibits favorable absorption profiles and low toxicity levels in preclinical models, making it a strong candidate for further development into clinical trials.

In conclusion, 5-Aza-7-deazaguanine (CAS No. 67410-64-4) is a versatile compound with a wide range of applications in modern science and medicine. Its unique chemical structure, combined with recent advancements in synthetic methodologies and therapeutic applications, positions it as a key molecule in future research endeavors. As ongoing studies continue to uncover new insights into its properties and potential uses, 5-Aza-7-deazaguanine is poised to make significant contributions to the fields of chemistry, biology, and medicine.

• 743467-43-8(IMIDAZO[1,2-A]-1,3,5-TRIAZIN-4(1H)-ONE, 2-[(2-METHYLPROPYL)AMINO]-)
• 878633-88-6(1,3,5-TRIAZINO[1,2-A]BENZIMIDAZOL-4(1H)-ONE, 2-AMINO-8-METHYL-)
• 865850-06-2(IMIDAZO[1,5-A]-1,3,5-TRIAZIN-4(1H)-ONE, 2-AMINO-, HYDRATE (2:3))
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)